Yuanxi Xu
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 10%
- Surgery
- Infectious Diseases
- Pulmonary and Respiratory Medicine
- Topics
- Streptococcal Infections and Treatments (5 papers)Peripheral Artery Disease Management (5 papers)Antimicrobial Resistance in Staphylococcus (4 papers)
- Journals
- Proceedings of the National Academy of SciencesPLoS ONEAntimicrobial Agents and Chemotherapy
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yuanxi Xu
23 papers receiving 449 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 158
- Cardiology and Cardiovascular Medicine 146
- Surgery 96
- Infectious Diseases 58
- Pulmonary and Respiratory Medicine 54
Countries citing papers authored by Yuanxi Xu
This map shows the geographic impact of Yuanxi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanxi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanxi Xu more than expected).
Fields of papers citing papers by Yuanxi Xu
This network shows the impact of papers produced by Yuanxi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanxi Xu. The network helps show where Yuanxi Xu may publish in the future.
Co-authorship network of co-authors of Yuanxi Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yuanxi Xu. A scholar is included among the top collaborators of Yuanxi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanxi Xu. Yuanxi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 54 | |
| 5 | 3 | |
| 6 | 16 | |
| 7 | 8 | |
| 8 | 17 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 69 | |
| 12 | 29 | |
| 13 | 28 | |
| 14 | 13 | |
| 15 | Predictive value of serum uric acid on cardiovascular disease and all-cause mortality in urban Chinese patients. | 24 |
| 16 | 55 | |
| 17 | 11 | |
| 18 | Effects of metoprolol on beta1 adrenergic receptor polymorphism and receptor density in urban Chinese patients with heart failure. | 11 |
| 19 | 5 | |
| 20 | 17 |
About Yuanxi Xu
Yuanxi Xu is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Orthodontics, having authored 24 papers that have together received 459 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (5 papers), Peripheral Artery Disease Management (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Health Informatics (9 citations), Cardiology and Cardiovascular Medicine (146 citations) and Nephrology (35 citations). Yuanxi Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hongmin Sun, Dayi Hu, Scott D. Larsen, Yibao Ma, Yongquan Wu, Roderick J. Sorenson, Ning Chen, Jue Li, Xuemei Lu and Xiaofei Ji. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.